Gladstone Institutes

Gladstone's mission is to drive a new era of discovery in disease-oriented science and to mentor tomorrow’s leaders in an inspiring and diverse environment.

[Gladstone Institutes @GladstoneInst]

This AI-powered microscope doesn’t just observe cells—it thinks, learns, and designs its own experiments.

See how it’s helping scientists uncover new paths to treating Parkinson’s disease and other neurodegenerative disorders.

https://t.co/o6Qv22CVKj

[Gladstone Institutes @GladstoneInst]

Researchers developed a new way to map how the brain clears waste. The study found this process is disrupted in inflammation and Alzheimer's, opening opportunities for future therapies.

#WorldBrainDay

https://t.co/ihcNBhsqDZ

[ShorterLab @ShorterLab]

Controlling oxygen to fight disease, via @EurekAlert! @GladstoneInst https://t.co/YvWlwfsyFD

[Gladstone Institutes @GladstoneInst]

New research from @ishahjain shows low oxygen can help alleviate disease caused by defects in a mitochondrial quality control machinery.

[Claude @claudeai]

🧪 Gladstone Institutes prize: Trialign by Jules Park (Toronto, Canada) and Neil Wang (San Francisco, CA)

A clinical trial matcher for cancer patients 
that reads their medical records and finds the studies they qualify for today.

[Cerebral Valley @cerebral_valley]

That's a wrap on Built with Claude: Life Sciences 🧬

To celebrate the launch of Claude Science, we partnered with @claudeai and @GladstoneInst to bring together researchers and builders worldwide to build with Claude Science and Claude Code.

$100K+ in Claude API credits on the line. Dozens of new methods applying AI to life sciences research.

Explore the projects 👇

[Gladstone Institutes @GladstoneInst]

Ever wonder what it's like working at Gladstone?

This gives you just a glimpse of the collaboration, creativity, and discovery that happens on a daily basis.

[Gladstone Institutes @GladstoneInst]

Check out this AFAR spotlight interview with @NaliniRRao, where she describes the potential impact of her Alzheimer's disease research.

https://t.co/kuSZFNQLq8

[Gladstone Institutes @GladstoneInst]

An RNA-triggered CRISPR system eliminates tumor cells by shredding their genetic material while sparing healthy cells.

https://t.co/D1zKRKNP2a

[Gladstone Institutes @GladstoneInst]

By uniting the power of single-cell sequencing, organoids, and artificial intelligence, scientists are entering a new era of HIV research.

https://t.co/GB6E1CgPLc

[Gladstone Institutes @GladstoneInst]

We're gearing up for the 2026 Bay Are Heart Walk!

Learn how you can support our team ➡️ https://t.co/Il62SEUrLR

[Gladstone Institutes @GladstoneInst]

Trialign by Jules Park (Toronto, Canada) and Neil Wang (San Francisco, CA) was selected as the Gladstone Institutes Prize Winner!

Watch this video to learn more about the project.

[Claude @claudeai]

🧪 Gladstone Institutes prize: Trialign by Jules Park (Toronto, Canada) and Neil Wang (San Francisco, CA)

A clinical trial matcher for cancer patients 
that reads their medical records and finds the studies they qualify for today.

[Claude @claudeai]

The Built with Claude: Life Sciences hackathon comes to an end.

Thank you to everyone who spent a week building with Claude Science and Claude Code, and to @gladstoneinst and @cerebral_valley for co-hosting.

Introducing the winners:

[Gladstone Institutes @GladstoneInst]

As tau-targeting therapies advance in clinical trials, Lennart Mucke shares optimism about the future of Alzheimer's treatment.

https://t.co/XsogE6DUxP

[ALS Network @youralsnetwork]

Exciting work from @youralsnetwork Scientific Advisory Committee member Steven Finkbeiner and Deepak Srivastava at @GladstoneInst demonstrating how AI-powered "thinking microscopes" could accelerate discovery for Parkinson's, Alzheimer's, ALS, and other neurodegenerative diseases.

Learn more about this work: https://t.co/p94ujI7Hfm

#alsresearch #aiinscience

[Friedman Brain Institute @SinaiBrain]

2 WEEKS AWAY! On Tues, July 28, 10am, the #BrainBodySeminarSeries is excited to welcome @GladstoneInst's @andcyang. Join hosts @cam_phd & @JM_Castell when Dr. Yang presents "Tracing proteomes & immune cells across the #BloodBrainBarrier". Register Now 👉 https://t.co/2p8ydIk6ce

[Molecular Neurodegeneration @MolNeuro]

Transplantation of human #iPSC-derived #microglia ameliorates #neuropathology and circuit dysfunction in #progranulin-deficient mice

Hayk Davtyan, Sarah Naguib, Yuliya Voskobiynyk... Jeanne T. Paz, Mathew Blurton-Jones, Li Gan #FrontotemporalDementia

https://t.co/9M0EoFJvvi

[Gladstone Institutes @GladstoneInst]

Lennart Mucke provides crucial scientific context on new Alzheimer's clinical data dominating headlines, drawing on his lab's pioneering discovery of tau's therapeutic potential.

https://t.co/bmdhbKEUe7

[Gladstone Institutes @GladstoneInst]

NOMIS–Gladstone Fellow Cathrine Sant (@cathrine_sant) is studying an enigmatic region of the human genome linked to neurodegenerative disease risk.

Sant is co-mentored by @ryancorces and Lennart Mucke.

https://t.co/zJqH2cA1Zg

[Gladstone Institutes @GladstoneInst]

Read more about this recent study: https://t.co/UGn5Kv2bpG

[Gladstone Institutes @GladstoneInst]

What if less oxygen could actually improve health?

[Gladstone Institutes @GladstoneInst]

Gladstone’s scientists are now developing HypoxyStat, a drug designed to deliver the benefits of hypoxia therapy through a pill or injection.